Clario vs Emedgene
ClarioClinical Trial Management
CustomPublished price
EmedgeneAI Report Generation
CustomPublished price
Clario Clinical Trial Management Clinical trial endpoint technology and evidence generation. | Emedgene AI Report Generation Germline variant interpretation | |
|---|---|---|
| Overview | ||
| Category | Clinical Trial Management | AI Report Generation |
| What it is | Clario provides clinical trial endpoint technology and data solutions for decentralized and site-based clinical trials across more than 100 countries. | AI-powered genomic interpretation platform from Illumina that automates variant prioritization and case reporting. |
| Pricing | ||
| Published price | Custom Enterprise clinical-trial services priced by quote per study; no public list price. Now part of Thermo Fisher (acquired 2025 for ~$8.9B) but still sold under the Clario brand. | Custom The product has been acquired, renamed, or folded into a successor offering. No reliable current standalone numeric price is publicly listed, so pricing requires confirmation from… |
| Pricing model | Custom quote | Custom quote |
| Free options | No free plan · No free trial | No free plan · Free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2021 | 2016 |
| Team size | 1001-5000 employees | 51-200 employees |
| Headquarters | Philadelphia, Pennsylvania | Tel Aviv, Israel |
| Featured clients | Johnson & Johnson, Merck, AbbVie | Not available |